Associations ask USP to extend comment deadline
In December, APC, APhA, and NCPA sent a joint letter to Brenda Jensen, chair of USP’s Compounding Expert Committee.
In December, APC, APhA, and NCPA sent a joint letter to Brenda Jensen, chair of USP’s Compounding Expert Committee.
Prescribers need to know the potential issues with USP’s proposals for beyond-use dates on compounded medication.
Shawn and Tara pushed back against misinformation about cBHT ... and looked good doing it.
He’s on the December America’s Pharmacist mag.
"Not a creature was stirring," indeed.
22 members of Congress urged FDA to “craft patient-centered policies that preserve treatment options” related to compounded hormones.
Mention this letter to your pharmacy board members and executive director.
It debuted last week.
The Kentucky Society of Association Executives has directed those who want to help to this list of local charity organizations.
How do you think currently proposed revisions to USP Chapters 795 and 797 will affect your patients and pharmacy practice? We need to hear from you, and soon!